Venlafaxine as the ‘baby ecstasy’? Literature overview and analysis of web‐based misusers′ experiences
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Introduction: Venlafaxine is one of the most frequently prescribed antidepressants worldwide, despite its toxicity risk in overdose. Furthermore, the molecule has been recently identified at the EU‐wide level as one of the novel psychoactive substances. This paper aims at investigating the potential of misuse, taking into account both the existing literature and the analysis of the misusers' experiences as described in venlafaxine misuse web reports. Methods: A literature search was performed using PubMed, Embase, and Medline. Posts/threads relating to venlafaxine misuse issues were identified through Google® and Yahoo® English‐language searches. Resulting websites' data were then qualitatively assessed, and information was collected on a range of issues, including dosage, drug intake modalities, untoward drug effects, and association with other recreational drugs. Results: A few literature case reports focusing on venlafaxine as a misusing drug were here identified. The molecule was here typically ingested or snorted at dosages up to 10–15 times higher than those clinically advised, obtaining MDMA/amphetamine‐like stimulant and psychedelic effects. Polydrug misuse was commonly reported. Venlafaxine appeared to be widely available online for sale. Conclusions: Physicians should carefully evaluate patients for history of drug dependence and observe them for signs of venlafaxine misuse. Copyright © 2015 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boyer, E. W., & Shannon, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041867 · Cited by 1,821
Muth, E. A., Haskins, J. T., Moyer, J. A., Husbands, G. E. M., Nielsen, S. T., & Sigg, E. B. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90769-0 · Cited by 374 · cited 3×
“Furthermore, preclinical studies showed that venlafaxine presents with a high affinity for D2 receptors (Muth et al., 1986; Shang et al., 2007), while its chronic administration is associated as well with D3 receptors’ adaptive changes (Maj et al.”
BackgroundNovel psychoactive substances of interest for psychiatry
Schifano, F., Orsolini, L., Duccio Papanti, G., & Corkery, J. M. (2015) · World Psychiatry · doi:10.1002/wps.20174 · Cited by 321
Self-citationEvidence of the dual mechanisms of action of venlafaxine
Harvey, A. T., Rudolph, R. L., & Preskorn, S. H. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.5.503 · Cited by 302 · cited 3×
“At high/very high dosages, venlafaxine presents as well with significant 5-HTergic activity (Redrobe et al., 1998; Harvey et al., 2000), hence mimicking the MDMA/ecstasy effects (Schifano, 2004).”
BackgroundMartinotti, G., Sepede, G., Gambi, F., Di Iorio, G., De Berardis, D., Di Nicola, M., Onofrj, M., Janiri, L., & Di Giannantonio, M. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31825d6c25 · Cited by 276
Toxicity of antidepressants: rates of suicide relative to prescribing and non-fatal overdose
Hawton, K., Bergen, H., Simkin, S., Cooper, J., Waters, K., Gunnell, D., & Kapur, N. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.070219 · Cited by 192 · cited 2×
“Venlafaxine, the first marketed serotonin–norepinephrine reuptake inhibitor (Wyeth Laboratories, 2006), has now become one of the most frequently prescribed antidepressants worldwide, despite some concerns about its toxicity in overdose (Buckley and McManus, 2002; Whyte et al., 2003; Cheeta et al., 2004; Morgan et al.…”
BackgroundRedrobe, J. P., Bourin, M., Colombel, M. C., & Baker, G. B. (1998) · Psychopharmacology · doi:10.1007/s002130050638 · Cited by 163
Venlafaxine treatment of fibromyalgia
Sayar, K., Aksu, G., Ak, I., & Tosun, M. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1d112 · Cited by 157 · cited 2×
“Its off-label prescription has been reported as well in fibromyalgia (Sayar et al., 2003), tension-type headache (Zissis et al.”
BackgroundWeikop, P., Kehr, J., & Scheel-Krüger, J. (2004) · Journal of Psychopharmacology · doi:10.1177/026988110401800311 · Cited by 57
Carrus, D., & Schifano, F. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318272864d · Cited by 49
Self-citation
Cited by
New/emerging psychoactive substances and associated psychopathological consequences
Schifano, F., Napoletano, F., Chiappini, S., Guirguis, A., Corkery, J. M., Bonaccorso, S., Ricciardi, A., Scherbaum, N., & Vento, A. (2021) · Psychological Medicine · doi:10.1017/s0033291719001727 · Cited by 119
Self-citationChiappini, S., & Schifano, F. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000814 · Cited by 44
Self-citationIs There a Potential of Misuse for Venlafaxine and Bupropion?
Schifano, F., & Chiappini, S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00239 · Cited by 38
Self-citationThe consequences of drug misuse on post-marketing surveillance
Schifano, F., Papanti, G. D., Orsolini, L., & Corkery, J. M. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2016.1178571 · Cited by 21
Self-citationComing Off Prescribed Psychotropic Medications: Insights from Their Use as Recreational Drugs
Schifano, F. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000507897 · Cited by 18
Self-citation
Metadata
- Authors
- Francesconi, G., Orsolini, L., Papanti, D., Corkery, J. M., & Schifano, F.
- Venue
- Human Psychopharmacology: Clinical and Experimental
- Publisher
- Wiley
- Published
- 2015-07
- Volume
- 30
- Issue
- 4
- Pages
- 255-261
- ISSN
- 0885-6222 (ISSN-L)
- 1099-1077
- OpenAlex
- W2148069408
- Cited by
- 22
- References
- 11
- FWCI
- 3.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Venlafaxine as the ‘baby ecstasy’? Literature overview and analysis of web‐based misusers′ experiences. https://app.cochat.ai/papers/10.1002/hup.2476
- The paper
- Francesconi, G., Orsolini, L., Papanti, D., Corkery, J. M., & Schifano, F. (2015). Venlafaxine as the ‘baby ecstasy’? Literature overview and analysis of web‐based misusers′ experiences. Human Psychopharmacology: Clinical and Experimental. https://doi.org/10.1002/hup.2476
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.